Knobbe Martens Earns Top Recognitions for IP Work in 2027 Best Law Firms Guide
IRVINE, Calif., November 5, 2026 – Knobbe Martens is proud to share that the firm has been recognized as a leading national intellectual property law firm across numerous categories in...
FDA’s New Neuroscience Initiative Highlights the Importance of Early, Adaptive Patent Strategy
Key Takeaway: The FDA’s new neuroscience initiative is designed to accelerate a new wave of biotechnology innovation, and with it, new opportunities for intellectual property protection. For companies developing neuroscience...
FDA Announces New Rare Disease Framework With Potential Implications for IP Strategy
Key Takeaway: On October 14, 2026, the FDA announced a proposed framework for rare disease drug development that aims to provide greater regulatory flexibility and disease-tailored evaluation. Increased regulatory clarity...
Subscribe for News and Updates
